Study Structure and Properties of Nanocomposite Material Based on Unsaturated Polyester with Clay Modified by Poly(ethylene oxide)

In recent years, polymer clay nanocomposites have been attracting considerable interests in polymers science because of their advantages. There are many scientists who researched about this kind of material and demonstrated that when polymer matrix was added to little weight of clay, properties were enhanced considerably. Because clay is a hydrophilic substance so it is difficult to use as filler in polymer matrix having hydrophobic nature, so clay needs to be modified to become compatible with polymer. In this study, poly(ethylene oxide) was used as a new modifier for clay to replace some traditional ionic surfactants such as primary, secondary, tertiary, and quaternary alkyl ammonium or alkylphosphonium cations having the following disadvantages: disintegrate at high temperature, catalyze polymer degradation, and make nanoproducts colorific, and so forth. In order to evaluate modifying effect of poly(ethylene oxide), modified clay products were characterize d by X-ray spectrum. Then organoclay was used to prepare nanocomposite based on unsaturated polyester. Morphology and properties of nanocomposites were measure d by X-ray diffraction, transmission electron microscopy, tensile strength, and thermal stability. The results showed that clay galleries changed to intercalated state in the nanocomposites. Properties of nanocomposites were improved a lot when the loading of the organoclay was used at 1 phr

PROBLEMS OF ENGLISH STUDIES STUDENTS ON LEARNING PHONOLOGY AND SUGGESTIONS, CAN THO UNIVERSITY, VIETNAM

The writers were concerned by the phonological challenges encountered by students of the Schools of Foreign Languages, Can Tho University. Foreign language majors are often difficult, and theory is quite tackled, which has caused many serious problems for students. This is no exception for students majoring in English Studies, at Can Tho University in the process of approaching the subject "Introduction to English Phonology". This study was conducted to clarify the phonological challenges that students at Can Tho University are facing, as well as suggest solutions to the problem of phonology learners. Using data from Google Questionnaire Forms, the research conducted an error analysis of 103 English majors who studied the subject. Based on the phonological problems, certain remedial activities were planned for the students, which helped improve their study process phonological problems considerably.   Article visualizations

An HPLC Quantitative Analysis of Paraquat in Human Plasma: A Helpful Tool for Diagnosis and Evaluation of Treatment of Paraquat Poisoning in Vietnamese Hospitals

In this paper, the paraquat (PQ) concentrations in plasma of poisoned patients were determined by high performance liquid chromatography (RP-HPLC) with a DAD detector followed simple extraction of PQ from plasma. The sample was simply pretreated with 15% trichloroacetic acid for deproteinization and directly injected to HPLC system. PQ in plasma was separated on a C8 column HPLC system using 2 channel mobile phase (A and B) with a volume ratio of 5:95, respectively. Channel A was 5% acetonitrile (ACN) and Channel B was a mixture of phosphate buffer (pH 2.5), sodium 1-heptanesulphonate (0.11% w / v), KCl (0.20% w / v), polyethylene glycol G400 (0.20% v / v) and methanol (20% v / v). The flow rate of mobile phase was 0.5 mL/min. The method detection limit (MDL) is 0.013 ?g/ mL and the quantitative limit is 0.040 ?g/ mL. The recovery of PQ in plasma samples was 96.1% - 105.9 % at 5 different concentrations ranging from 0.040 ?g / mL to 10.00 ?g/ mL. The within- and between-day relative standard deviations were all less than 0.82% and 1.43% respectively. The method was successfully applied for determining paraquat concentrations in plasma samples of 31 acute paraquat poisoned patients at Poison Control Center, Bach Mai hospital, Vietnam. Quantitative results revealed that plasma PQ level was a key factor for prognosis and hemoperfusion using resin membrane had significant effect in removing PQ from the blood

Pencil lead graphite electrochemically modified with polyglutamic acid as a sensor for detection of enrofloxacin in aqueous media

This study investigates the modification of pencil lead graphite electrodes with polyglutamic acid using an effective and fast static method to develop a sensor for the detection of enrofloxacin (ENR). The successful fabrication of pGA on the electrode surface was confirmed by scanning electron microscopy, energy dispersive X-ray analysis, and Fourier-transform infrared spectroscopy. The conditions of electrochemical modification, including the applied potentials and number of cycles in the potentiostatic process, were systematically investigated to determine their effects on the ENR electrochemical response. The pH of the electrolyte media was also explored to elucidate the electrochemical reaction mechanism of ENR. The developed electrochemical sensor was evaluated using square wave stripping voltammetry for ENR detection. Under optimal conditions, the sensor demonstrated good reproducibility with a relative standard deviation of 4.3% (from five measurements) for ENR signal detection. A linear relationship between ENR concentration and its peak current was observed in the concentration range of 0.1 to 5 µM, with a high correlation coefficient of 0.9988. The limit of detection for ENR using the sensor was 0.12 µM. Our findings provide valuable insights into the design and optimisation of pencil lead graphite electrode-based sensors for ENR detection in aqueous media

A generic assay for whole-genome amplification and deep sequencing of enterovirus A71

Enterovirus A71 (EV-A71) has emerged as the most important cause of large outbreaks of severe and sometimes fatal hand, foot and mouth disease (HFMD) across the Asia-Pacific region. EV-A71 outbreaks have been associated with (sub)genogroup switches, sometimes accompanied by recombination events. Understanding EV-A71 population dynamics is therefore essential for understanding this emerging infection, and may provide pivotal information for vaccine development. Despite the public health burden of EV-A71, relatively few EV-A71 complete-genome sequences are available for analysis and from limited geographical localities. The availability of an efficient procedure for whole-genome sequencing would stimulate effort to generate more viral sequence data. Herein, we report for the first time the development of a next-generation sequencing based protocol for whole-genome sequencing of EV-A71 directly from clinical specimens. We were able to sequence viruses of subgenogroup C4 and B5, while RNA from culture materials of diverse EV-A71 subgenogroups belonging to both genogroup B and C was successfully amplified. The nature of intra-host genetic diversity was explored in 22 clinical samples, revealing 107 positions carrying minor variants (ranging from 0 to 15 variants per sample). Our analysis of EV-A71 strains sampled in 2013 showed that they all belonged to subgenogroup B5, representing the first report of this subgenogroup in Vietnam. In conclusion, we have successfully developed a high-throughput next-generation sequencing-based assay for whole-genome sequencing of EV-A71 from clinical samples

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Tyrosinase Inhibitors from the Wood of <i>Artocarpus heterophyllus</i>

From the methanolic-soluble extract of the wood of <i>Artocarpus heterophyllus</i>, four new flavones, artocarmins A–D (<b>1</b>–<b>4</b>), and three new chalcones, artocarmitins A–C (<b>5</b>–<b>7</b>), have been isolated together with 13 known compounds. Their structures were determined on the basis of the spectroscopic data. Compounds <b>1</b>–<b>4</b>, <b>6</b>, <b>7</b>, <b>9</b>–<b>16</b>, and <b>20</b> displayed significant tyrosinase inhibitory activity. The most active compound, morachalcone A (<b>12</b>) (IC₅₀, 0.013 μM), was 3000 times more active as a tyrosinase inhibitor than a positive control, kojic acid (IC₅₀, 44.6 μM)